CD24 and cancer: Additionally, the MFI of the cancer stemness marker CD24 was significantly associated with the percentage of GSHlo MITOhi CD34+ cells (Supplementary Fig. 4d–f), suggesting a mirrored effect of cell metabolic status on EV surface expression markers.